Healthcare
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Trend Stats
1-Month Return
+4.10%
3-Month Return
+10.32%
12-Month Return
+24.06%
Volatility Score
1.5
RSI
62.3
ST Trend
Neutral
LT Trend
Up
Short-Term Trend
Neutral
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Healthcare
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co | $1.1T | +47.16% | +5.03% | +6.19% | 2.8 | Neutral | Up |
| JNJ | Johnson&Johnson | $612B | +35.81% | +0.52% | -4.66% | 2.2 | Down | Up |
| ABBV | AbbVie | $501B | +28.27% | +16.63% | +8.29% | 2.1 | Up | Up |
| MRK | Merck | $364B | +80.36% | +22.74% | +2.34% | 2.4 | Neutral | Up |
| UNH | Unitedhealth Gro | $355B | +12.46% | -6.38% | +3.15% | 2.4 | Neutral | Up |
| TMO | Thermo Fisher Sc | $249B | +27.98% | +26.15% | +9.79% | 2.7 | Up | Up |
| AMGN | Amgen | $230B | +47.29% | +20.65% | +11.69% | 2.4 | Up | Up |
| GILD | Gilead Sciences | $190B | +33.00% | +18.74% | +5.46% | 2.4 | Up | Up |
| ABT | Abbott Laborator | $178B | -18.98% | +16.57% | -0.12% | 2.1 | Down | Neutral |
| PFE | Pfizer | $166B | +28.16% | +22.56% | +5.38% | 1.8 | Up | Up |
| DHR | Danaher | $158B | +9.82% | +13.08% | +10.74% | 2.8 | Up | Up |
| ISRG | Intuitive Surgic | $148B | -3.53% | +10.74% | +11.19% | 2.6 | Up | Down |
| VRTX | Vertex Pharma | $126B | +22.21% | +4.66% | -4.04% | 2.4 | Down | Up |
| BMY | Bristol-MyersSqu | $121B | +41.98% | +5.17% | -6.56% | 2.7 | Down | Neutral |
| MDT | Medtronic | $121B | +2.11% | +19.80% | +1.28% | 2.4 | Up | Up |
| CVS | CVS Health | $116B | +15.61% | -14.34% | -5.40% | 2.5 | Down | Up |
| MCK | Mckesson | $114B | +23.80% | +21.69% | +7.20% | 2.3 | Up | Up |
| SYK | Stryker | $108B | -22.99% | -9.18% | +0.23% | 2.5 | Down | Down |
| HCA | HCA Healthcare | $102B | +12.71% | +29.62% | +10.77% | 2.5 | Up | Up |
| ELV | Elevance Health | $93B | +24.93% | +0.74% | +0.91% | 2.3 | Up | Up |
| MRNA | MODERNA | $90B | +716.38% | +235.56% | +54.27% | 6.9 | Up | Up |
| REGN | Regeneron Pharma | $80B | +35.73% | +18.77% | -1.94% | 2.7 | Down | Up |
| CI | The Cigna | $77B | +0.53% | -4.01% | -0.16% | 2.5 | Up | Up |
| COR | Cencora | $64B | +5.98% | +11.43% | +3.05% | 2.3 | Up | Up |
| BSX | Boston Scientifi | $62B | -55.99% | +0.87% | -4.55% | 2.6 | Down | Down |
| CAH | Cardinal Health | $57B | +60.65% | +7.91% | +5.72% | 2.3 | Up | Up |
| BDX | Becton Dickinson | $51B | +3.66% | +26.12% | +3.27% | 2.0 | Up | Up |
| HUM | Humana | $51B | +64.80% | +5.07% | +5.01% | 4.1 | Up | Up |
| EW | Edwards Lifescns | $50B | +18.54% | -4.04% | +1.09% | 2.4 | Down | Neutral |
| A | Agilent Tech | $49B | +25.53% | +28.89% | +18.71% | 2.9 | Up | Up |
| VEEV | Veeva Systems-A | $48B | +3.47% | +54.00% | +11.92% | 2.9 | Up | Up |
| IQV | IQVIA Holdings | $43B | +28.99% | +26.07% | -1.38% | 2.7 | Neutral | Up |
| WAT | Waters | $43B | +31.35% | +16.00% | +6.49% | 2.9 | Up | Up |
| IDXX | IDEXX Labs | $42B | -17.23% | -2.16% | +3.82% | 2.3 | Down | Down |
| ILMN | Illumina | $41B | +192.22% | +42.13% | +30.52% | 5.3 | Up | Up |
| CNC | Centene | $35B | +96.03% | +2.10% | +1.08% | 3.0 | Up | Up |
| BIIB | Biogen | $34B | +62.07% | +21.30% | +7.12% | 2.6 | Up | Up |
| RMD | Resmed | $33B | -11.84% | +22.26% | +5.52% | 2.0 | Up | Up |
| MTD | Mettler Toledo I | $32B | +23.41% | +22.39% | +25.16% | 2.8 | Up | Up |
| DXCM | Dexcom | $31B | +27.61% | +12.61% | -1.43% | 2.5 | Down | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |